PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.06
0.06 - 0.24
2.78M / 3.59M (Avg.)
-1.55 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
73317.96%
10Y CAGR of 73317.96% while SMR.AX is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
73317.96%
Positive 5Y CAGR while SMR.AX is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
28.58%
OCF/share CAGR of 28.58% while SMR.AX is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
28.58%
OCF/share CAGR of 28.58% while SMR.AX is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
-171.61%
Negative 3Y OCF/share CAGR while SMR.AX stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
181.61%
10Y net income/share CAGR of 181.61% while SMR.AX is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
181.61%
5Y net income/share CAGR above 1.5x SMR.AX's 100.00%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
29.82%
Below 50% of SMR.AX's 100.00%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
-103.58%
Negative equity/share CAGR over 10 years while SMR.AX stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-103.58%
Negative 5Y equity/share growth while SMR.AX is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-104.87%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.